October 9, 2024: FDA Determines Terzepatide Shortage is Over
By addressing inflammation, semaglutide therapy not only aids in weight loss but also has potential benefits for inflammatory-related conditions
(R-KS) sent a bipartisan letter to the FDA flagging Hims & Hers' ad and accusing the company of misleading patients "by omitting any safety or side effect information when promoting a specific type of weight loss medication." Under federal law and regulations, FDA requires that prescription drug advertisements be truthful, not misleading, and balancedfailure to do so risks FDA enforcement action, including civil monetary penalties, Durbin and Marshall said in the letter
Gil-Lozano M, Romani-Prez M, Outeirio-Iglesias V, Vigo E, Gonzlez-Matas LC, Brubaker PL, et al
For the average person using glutathione for wellness and antioxidant support, the risk of "causing" grey hair is extremely low
Bain, G.L